Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Gift Director gave 300,000 shares (gift)
  2. 4 Exercise or conversion Director acquired 46,000 shares (option exercise)
  3. 4 Other acquisition President acquired 1,086 shares (other)
  4. 4 Open-market buy Director bought 10,000 shares at $2.79 ($27,900)
  5. 4 Open-market buy President bought 5,500 shares at $2.66 ($14,630)
  6. 4 Open-market buy President bought 2,509 shares at $2.53 ($6,348)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Director bought 5,000 shares at $3.28 ($16,400)
  14. 4 Open-market buy Director bought 2,000 shares at $3.20 ($6,400)
  15. 4 Open-market buy Director bought 6,000 shares at $3.08 ($18,480)
  16. 4 Open-market buy Director bought 11,000 shares at $3.08 ($33,880)
  17. 4 Open-market buy Chief Executive Officer bought 20,000 shares at $3.00 ($60,000)
  18. 4 Other acquisition COO & CFO acquired 743 shares (other)
  19. 4 Open-market buy Director bought 18,244 shares at $4.76 ($86,841)
  20. 4 Open-market buy Chief Executive Officer bought 2,000 shares at $4.77 ($9,540)

Page 5 of 24 · 471 filings